These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32627043)

  • 1. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
    Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
    Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
    Kato K; Gong J; Iwama H; Kitanaka A; Tani J; Miyoshi H; Nomura K; Mimura S; Kobayashi M; Aritomo Y; Kobara H; Mori H; Himoto T; Okano K; Suzuki Y; Murao K; Masaki T
    Mol Cancer Ther; 2012 Mar; 11(3):549-60. PubMed ID: 22222629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
    Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
    Kobara H; Fujihara S; Iwama H; Matsui T; Fujimori A; Chiyo T; Tingting S; Kobayashi N; Nishiyama N; Yachida T; Tadokoro T; Oura K; Tani J; Fujita K; Nomura T; Yoneyama H; Morishita A; Okano K; Suzuki Y; Mori H; Masaki T
    Mol Med Rep; 2020 Aug; 22(2):1063-1071. PubMed ID: 32626983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
    Matsui T; Chiyo T; Kobara H; Fujihara S; Fujita K; Namima D; Nakahara M; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Iwama H; Masaki T
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
    Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
    Yamana Y; Fujihara S; Kobara H; Oura K; Samukawa E; Chiyo T; Okamura M; Yamana H; Tadokoro T; Fujita K; Morishita A; Iwama H; Masaki T
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S305-S312. PubMed ID: 36510981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
    Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
    Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G
    Tsujiya Y; Yamamori M; Hasegawa AI; Yamamoto Y; Yashiro M; Okamura N
    Anticancer Res; 2021 Nov; 41(11):5461-5468. PubMed ID: 34732415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
    Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
    Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
    Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
    Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
    Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
    PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
    Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
    PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.